Collagen remodeling after myocardial infarction in the rat heart

• Published in: The American journal of pathology Vol. 147; no. 2; pp. 325 - 338
• Main Authors: Cleutjens, JP, Verluyten, MJ, Smiths, JF, Daemen, MJ
• Format: Journal Article
• Language: English
• Published: Bethesda, MD ASIP 01.08.1995; American Society for Investigative Pathology
• Subjects: Animals; Biological and medical sciences; Blotting, Northern; Cardiology. Vascular system; Collagen - genetics; Collagen - physiology; Coronary heart disease; Heart; Heart - physiopathology; Hydroxyproline - metabolism; Immunohistochemistry; In Situ Hybridization; Male; Medical sciences; Myocardial Infarction - pathology; Myocardial Infarction - physiopathology; Myocardium - metabolism; Myocardium - pathology; Procollagen - genetics; Rats; Rats, Wistar; RNA, Messenger - metabolism; Immunohistochemistry; Infarct; Rat; In situ; Rodentia; Cardiovascular disease; Hybridization; Coronary heart disease; Myocardial disease; Northern blotting; Pathology; Vertebrata; Experimental disease; Mammalia; Messenger RNA; Animal; Collagen; Myocardium; Molecular biology
• ISSN: 0002-9440; 1525-2191

In this study changes in the amount and distribution of types I and III collagen mRNA and protein were investigated in the rat heart after induction of a left ventricular myocardial infarction (MI). Sham operated rats served as controls. The animals were sacrificed at different time intervals after operation. Northern blotting of cardiac RNA and hybridization with cDNA probes for types I and III procollagen revealed a 5- to 15-fold increase in the infarcted left ventricle. Type III procollagen mRNA levels were already increased at day 2 after MI, whereas type I procollagen mRNA followed this response at day 4 after MI. This increase was sustained for at least 21 days in the infarcted left ventricle for type III procollagen mRNA, whereas type 1 procollagen mRNA levels were still elevated at 90 days after MI. In the noninfarcted right ventricle a 5- to 7-fold increase was observed for both type I and type III procollagen mRNA levels, but only at day 4 after MI. In the non-infarcted septum a transient increase was observed for type I procollagen mRNA from day 7-21 (4- to 5-fold increase) and a decline to sham levels thereafter. In the septum type III procollagen mRNA levels were only elevated at 7 days after MI (4- to 5-fold increase) compared with sham operated controls. In situ hybridization with the same types I and III procollagen probes showed procollagen mRNA-producing cells in the infarcted area around necrotic cardiomyocytes, and in the interstitial cells in the non-infarcted part of the myocardium. No labeling was detected above cardiomyocytes. Combined in situ hybridization and immunohistochemistry showed that the collagen mRNA producing cells have a myofibroblast-like phenotype in the infarcted myocardium and are fibroblasts in the noninfarcted septum and right ventricle. The increase in types I and III procollagen mRNA in both infarcted and non-infarcted myocardium was followed by an increased collagen deposition, measured by computerized morphometry on sirius red-stained tissue sections as well as by the hydroxyproline assay. In the non-infarcted septum and right ventricle the collagen-positive area was maximal at day 14 (3- to 5-fold increase compared with sham operated controls) and slightly declined at day 21. In the infarcted myocardium the collagen-positive area was 57 +/- 10% at day 14 after MI. Hydroxyproline contents were significantly increased in the noninfarcted septum.